All In MedTech

Device Trial Radar · NCT05981911

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease

Last checked: Nov 21, 2026Latest source record: Jan 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

2,000

Planned (sponsor's estimate)

Start

Dec 14, 2023

Primary completion

Jun 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Seung-Jung ParkAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
CardioVascular Research Foundation, Korea
First posted
Aug 8, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.

Conditions

  • Coronary Artery Disease

Interventions

  • XIENCE Skypoint™ stentDevice

    Percutaneous coronary intervention with Xience-Skypoint™ stent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the composite event rate of death, nonfatal myocardial infarction (MI), or ischemic-driven Target- Vessel Revascularization (TVR)Time frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asan Medical Hospital

    Seoul, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.